Main menu button

News

Analysis Samhällsbyggnadsbolaget i Norden: Large cash position add opportunities
30 Oct 2019
Analysis Samhällsbyggnadsbolaget i Norden: Large cash position add opportunities
Equity Research
Analysis, Preview Coor Q3: Stability is the key
28 Oct 2019
Analysis, Preview Coor Q3: Stability is the key
Equity Research
Analysis, Lammhults: On the road to fullfilling goals
28 Oct 2019
Analysis, Lammhults: On the road to fullfilling goals
Equity Research
Analysis Fastpartner: Aiming at new acquisitions
28 Oct 2019
Analysis Fastpartner: Aiming at new acquisitions
Equity Research
Analysis Raytelligence: The first order received
24 Oct 2019
Analysis Raytelligence: The first order received
Equity Research
Analysis, AdderaCare: A fresh start
23 Oct 2019
Analysis, AdderaCare: A fresh start
Equity Research
Q3 2019 preview SBB i Norden: Stability should be rewarded
22 Oct 2019
Q3 2019 preview SBB i Norden: Stability should be rewarded
Equity Research
Analysis Kopy Goldfields: New exploration
14 Oct 2019
Analysis Kopy Goldfields: New exploration
Equity Research
Analysis Calliditas: Great value can be released
10 Oct 2019
Analysis Calliditas: Great value can be released
Equity Research
Analysis Miris: Still waiting for the US
01 Oct 2019
Analysis Miris: Still waiting for the US
Equity Research
Analysis CLS: Awaiting Thermoguide
16 Sep 2019
Analysis CLS: Awaiting Thermoguide
Equity Research
Analysis Amasten: Construction of new residentials create value
11 Sep 2019
Analysis Amasten: Construction of new residentials create value
Equity Research
Analysis Brighter: News creates lower risk
10 Sep 2019
Analysis Brighter: News creates lower risk
Equity Research
Analysis Speqta: Strong growth in client base
04 Sep 2019
Analysis Speqta: Strong growth in client base
Equity Research
Analysis MultiDocker: Weak result, though improved gross margins
04 Sep 2019
Analysis MultiDocker: Weak result, though improved gross margins
Equity Research
Analysis VibroSense: A case of nerves
03 Sep 2019
Analysis VibroSense: A case of nerves
Equity Research
Analysis Biovica: Good progress in FDA discussions
02 Sep 2019
Analysis Biovica: Good progress in FDA discussions
Equity Research
Analysis Consilium: Proven result improvement
29 Aug 2019
Analysis Consilium: Proven result improvement
Equity Research
Analysis, New Wave Group: Investment for growth
29 Aug 2019
Analysis, New Wave Group: Investment for growth
Equity Research
Analysis Aspire: Growth in line with expectation
29 Aug 2019
Analysis Aspire: Growth in line with expectation
Equity Research